Medasense Biometrics Ltd.

15, Hahilazon Street, 5252279 Ramat Gan

Telephone +972 73 7690321
Fax +972 3 5183878

This company is co-exhibitor of
Israel Export & International Cooperation Institute


Hall map

MEDICA 2016 hall map (Hall 16): stand G40

Fairground map

MEDICA 2016 fairground map: Hall 16

Our range of products

Product categories

  • 01  Electromedical equipment / Medical Technology
  • 01.04  Intense medicine / anesthesiology / respiration
  • 01.04.04  Patient monitoring systems / Measuring stations

Patient monitoring systems / Measuring stations

  • 01  Electromedical equipment / Medical Technology
  • 01.04  Intense medicine / anesthesiology / respiration
  • 01.04.04  Patient monitoring systems / Measuring stations
  •  Operation monitoring equipment

Operation monitoring equipment

Our products

Product category: Patient monitoring systems / Measuring stations, Operation monitoring equipment

The Need for Objective Assessment of Pain

Managing pain is a primary medical function, as it affects quality of life for millions of patients and is often an indicator of underlining medical problems. In spite of the importance and prevalence of pain, there are currently no clinically accepted tools to objectively monitor changes in pain level, requiring physicians to rely on patients’ subjective assessment, or to simply guess, when patients – whether sedated, demented, or too young – cannot describe their pain. Lack of objective and timely assessment of pain leaves many patients either under-treated or overdosed.

Annual healthcare costs associated with pain exceed $300 billion in the U.S. alone. Pain is the most common reason for medical consultation. 40% of the 30 million patients undergoing surgery each year continue to suffer from severe pain after surgery, while 15,000 people die every year of overdoses involving prescription painkillers.

There is a general consensus among healthcare providers that an objective assessment of pain could revolu-tionize pain management, contributing to better clinical outcomes and to decreased costs. Considering the im-portance of recognizing in a timely manner changes in patient’s pain level – whether in the hospital, or when treated in the clinic and even at home – monitoring the body’s reactions to pain might become ubiquitous and a standard practice, just as the monitoring of other common vital signs such as blood pressure, heart rate and blood oxygen levels.

More Less

About us

Company details

Medasense Biometrics Ltd. is an early-stage medical device company specializing in innovative pain monitoring solutions. Medasense’s mission is to reduce pain suffering through developing innovative technological solutions that can more accurately measure a patients’ pain level, resulting in improved pain treatment.

Medasense has developed a patented pain monitoring device that can accurately and objectively measure the physiological response to pain, providing new insights into pain management care.  The non-invasive and easy-to-use pain monitor identifies a patient’s unique signature of pain by combining multiple pain-related physiological signals using state-of-the-art signal processing and pattern recognition algorithms. The feasibility of the technology was successfully demonstrated in various clinical trial settings, which have been published in distinguished peer-reviewed journals and presented at key conferences.

Medasense targets the multi-billion dollar pain monitoring market.  Its initial application will focus on the Operating Room, followed by the Intensive Care Unit, including the neonatal unit and then within Clinics and the Home Care Environment to treat chronic pain patients.

Medasense’s passionate and creative culture combined with its multi-skilled team of engineers, algorithm specialists, experienced business managers and pain management experts, strongly positions Medasense as a company that can bring exciting technological solutions to the pain management market.

Medasense was founded in 2008 and graduated from the technology incubator program of the Israeli office of chief scientists. It is financed and supported both by private investors and by a prominent manufacturer of pain diagnostic medical systems, Medoc Ltd.

More Less